MX2024004568A - Composiciones de trem y metodos de uso. - Google Patents

Composiciones de trem y metodos de uso.

Info

Publication number
MX2024004568A
MX2024004568A MX2024004568A MX2024004568A MX2024004568A MX 2024004568 A MX2024004568 A MX 2024004568A MX 2024004568 A MX2024004568 A MX 2024004568A MX 2024004568 A MX2024004568 A MX 2024004568A MX 2024004568 A MX2024004568 A MX 2024004568A
Authority
MX
Mexico
Prior art keywords
methods
trem
compositions
trna
naturally occurring
Prior art date
Application number
MX2024004568A
Other languages
English (en)
Spanish (es)
Inventor
William F Kiesman
Neil Kubica
Nikolai Naryshkin
Theonie Anastassiadis
Qingyi Li
Hongchuan Yu
David Charles Donnell Butler
Wetie Armand Gatien Ngounou
Stephen William Eichhorn
Christopher E Arcadia
Original Assignee
Flagship Pioneering Innovations Vi Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flagship Pioneering Innovations Vi Llc filed Critical Flagship Pioneering Innovations Vi Llc
Publication of MX2024004568A publication Critical patent/MX2024004568A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/531—Stem-loop; Hairpin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MX2024004568A 2021-10-13 2022-10-13 Composiciones de trem y metodos de uso. MX2024004568A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163255426P 2021-10-13 2021-10-13
US202163255420P 2021-10-13 2021-10-13
US202163284946P 2021-12-01 2021-12-01
US202163284934P 2021-12-01 2021-12-01
PCT/US2022/046632 WO2023064513A2 (en) 2021-10-13 2022-10-13 Trem compositions and methods of use

Publications (1)

Publication Number Publication Date
MX2024004568A true MX2024004568A (es) 2024-06-28

Family

ID=85987785

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024004568A MX2024004568A (es) 2021-10-13 2022-10-13 Composiciones de trem y metodos de uso.

Country Status (11)

Country Link
US (1) US20240401047A1 (cg-RX-API-DMAC7.html)
EP (1) EP4416288A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024538097A (cg-RX-API-DMAC7.html)
KR (1) KR20240107319A (cg-RX-API-DMAC7.html)
CN (1) CN120418430A (cg-RX-API-DMAC7.html)
AU (1) AU2022362286A1 (cg-RX-API-DMAC7.html)
CA (1) CA3235264A1 (cg-RX-API-DMAC7.html)
IL (1) IL311867A (cg-RX-API-DMAC7.html)
MX (1) MX2024004568A (cg-RX-API-DMAC7.html)
TW (1) TW202325313A (cg-RX-API-DMAC7.html)
WO (1) WO2023064513A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025080866A1 (en) * 2023-10-10 2025-04-17 Hc Bioscience, Inc. Trna therapeutics for hemophilia
CN117805381B (zh) * 2024-02-29 2024-05-28 首都医科大学附属北京积水潭医院 检测Gasdermin蛋白家族的物质在制备检测骨肉瘤的产品中的应用
WO2026073261A1 (en) * 2024-09-30 2026-04-02 Flagship Pioneering Innovations Vi, Llc Lipid nanoparticle formulations of trems
WO2026080471A2 (en) * 2024-10-07 2026-04-16 Flagship Pioneering Innovations Vi, Llc Compositions of trem conjugates and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5679147B2 (ja) * 2008-02-07 2015-03-04 独立行政法人理化学研究所 非天然塩基を含む改変tRNA及びその用途
WO2020069194A1 (en) * 2018-09-26 2020-04-02 Case Western Reserve University Methods and compositions for treating a premature stop codon-mediated disorder
JP2022534988A (ja) * 2019-05-31 2022-08-04 フラッグシップ パイオニアリング, インコーポレイテッド tRNAプールを調節するためのTREMの使用
JP7712270B2 (ja) * 2019-11-01 2025-07-23 テバード バイオサイエンシズ インコーポレイテッド 未成熟終止コドン媒介障害を処置するための方法および組成物
WO2021142343A1 (en) * 2020-01-09 2021-07-15 The Regents Of The University Of California Targeting transfer rna for the suppression of nonsense mutations in messenger rna
BR112022020780A2 (pt) * 2020-04-14 2022-11-29 Flagship Pioneering Innovations Vi Llc Composições de trem e usos das mesmas
US20230203510A1 (en) * 2020-05-29 2023-06-29 Flagship Pioneering Innovations Vi, Llc Trem compositions and methods relating thereto
KR20230135585A (ko) * 2020-12-23 2023-09-25 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 변형된 trem의 조성물 및 이의 용도

Also Published As

Publication number Publication date
US20240401047A1 (en) 2024-12-05
AU2022362286A1 (en) 2024-05-02
TW202325313A (zh) 2023-07-01
WO2023064513A9 (en) 2024-08-02
JP2024538097A (ja) 2024-10-18
WO2023064513A3 (en) 2023-06-15
KR20240107319A (ko) 2024-07-09
CN120418430A (zh) 2025-08-01
WO2023064513A2 (en) 2023-04-20
EP4416288A2 (en) 2024-08-21
IL311867A (en) 2024-06-01
CA3235264A1 (en) 2023-04-20

Similar Documents

Publication Publication Date Title
MX2022012955A (es) Composiciones de trem y usos de las mismas.
WO2023064513A3 (en) Trem compositions and methods of use
WO2021127283A3 (en) Irak degraders and uses thereof
PH12022551524A1 (en) Irak degraders and uses thereof
SA519402400B1 (ar) تركيبات وطرق لعلاج أمراض الهيموجلوبين
PH12023500015A1 (en) Irak degraders and uses thereof
MX2022001328A (es) Inhibidor de proteina quinasa quinasa activada por mitogeno (mek) para el tratamiento de apoplejia.
MX2021014441A (es) Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos.
AU2020317609A8 (en) Novel heteroaryl-triazole compounds as pesticides
MX2021012216A (es) Degradadores de transductores de señal y activadores de transcripción (stat) y usos de los mismos.
EP4477220A3 (en) Plasma kallikrein inhibitors and uses thereof
CR20230077A (es) Mezclas fungicidas
PH12022551522A1 (en) Smarca degraders and uses thereof
PH12023500023A1 (en) Cdk2 degraders and uses thereof
WO2021022163A3 (en) Compounds and uses thereof
WO2020123816A3 (en) Anellosomes and methods of use
MX2022005362A (es) Composiciones de trem para codones con-raros y usos relacionados.
GB2568181A (en) Wheat
MX2024001243A (es) Composiciones y metodos para el tratamiento de melanoma.
WO2019183215A3 (en) Halloysite-based nanocomposites and methods of making and using the same
MX2021010458A (es) Uso de virus oncoliticos para el tratamiento del cancer.
MX2022001641A (es) Composiciones fermentadas y procedimientos de preparacion de las mismas.
EP4331683A3 (en) Methods and compositions for the treatment of hair loss
WO2020021480A3 (en) Compositions and methods for treating the eye
EP4524225A3 (en) Protease variants and detergent compositions comprising same